Biotech IPOs Nudge 1 Firm Ahead of Peers In Quiet February

One firm squeezed ahead of peers guiding initial public offerings in February, a quiet month that closed only four biotech deals plus one from a blank check company, while four companies...

Already a subscriber? Click here to view full article